citalopram has been researched along with lisdexamfetamine dimesylate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cutler, AJ; Gao, J; Geibel, BB; Lasser, R; Patkar, AA; Richards, C; Sambunaris, A; Trivedi, MH | 1 |
Folgering, JH; Heins, MS; Hutson, PH | 1 |
Correa, M; Hutson, PH; Lopez-Cruz, L; Salamone, JD; Yohn, SE | 1 |
Brawman-Mintzer, O; Dauphin, M; Gao, J; Geibel, B; Madhoo, M; McIntyre, RS; Richards, C; Sambunaris, A; Weisler, R | 1 |
Dauphin, M; Geibel, B; Iosifescu, DV; Mago, R; Reynolds, J; Richards, C; Sarkis, E | 1 |
3 trial(s) available for citalopram and lisdexamfetamine dimesylate
Article | Year |
---|---|
A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Central Nervous System Stimulants; Citalopram; Depressive Disorder, Major; Dextroamphetamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lisdexamfetamine Dimesylate; Male; Middle Aged; Personality Inventory; Psychometrics; Young Adult | 2013 |
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Least-Squares Analysis; Lisdexamfetamine Dimesylate; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.
Topics: Adult; Antidepressive Agents; Blood Pressure; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Venlafaxine Hydrochloride | 2017 |
2 other study(ies) available for citalopram and lisdexamfetamine dimesylate
Article | Year |
---|---|
Effects of lisdexamfetamine alone and in combination with s-citalopram on acetylcholine and histamine efflux in the rat pre-frontal cortex and ventral hippocampus.
Topics: Acetylcholine; Animals; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Citalopram; Dextroamphetamine; Drug Therapy, Combination; Hippocampus; Histamine Release; Lisdexamfetamine Dimesylate; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2015 |
Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.
Topics: Animals; Behavior, Animal; Choice Behavior; Citalopram; Drug Interactions; Feeding Behavior; Lisdexamfetamine Dimesylate; Male; Motivation; Rats; Rats, Sprague-Dawley; Reward; Selective Serotonin Reuptake Inhibitors | 2016 |